Patient info Open main menu

Ametop gel 4% w/w – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Pharmacy medicine (P) Details

Medicine strength:
4% w/w (40 mg/gram)
Contains active substance:
ATC code:

Patient leaflet - Ametop gel 4% w/w

1. What AMETOP Gel is and what it is used for

AMETOP Gel contains the active substance tetracaine. Tetracaine is a local anaesthetic which numbs the skin.

AMETOP Gel is used:

  • to relieve the pain when needles are inserted into a vein for giving an injection or taking a blood sample.
  • to relieve the pain of inserting small plastic tubes (cannulae) into veins for putting up drips. AMETOP Gel is used in adults and infants aged over 1 month.

2. What you need to know before you use AMETOP Gel

Do not use AMETOP Gel:

  • if you are allergic (hypersensitive) to tetracaine or any of the other ingredients of AMETOP Gel (see Section 6).
  • if you are allergic (hypersensitive) to any other local anaesthetics.
  • if you are pregnant or breast-feeding.

  • if the patient is less than 1 month old.
  • if the patient is a premature baby up until one month after the expected delivery date (44 weeks gestation).
  • on wounds
  • on broken skin
  • on lips, mouth or tongue
  • on eyes or ears
  • on anal and genital regions.

Warnings and precautions

Talk to your doctor or pharmacist before using this medicine

  • it may be toxic to the ear, therefore you should not put AMETOP Gel in the ear or use it for any middle ear procedures.
  • if you suffer from epilepsy.

Do not swallow AMETOP Gel

Children

Do not use this medicine in infants less than 1 month old or in premature babies up until one month after the expected delivery date (44 weeks gestation). Other medicines and AMETOP Gel

Tell your doctor or pharmacist if you are taking or have recently taken any medicines, including medicines obtained without a prescription. Pregnancy and breast-feeding

Do not use if you are pregnant, thinking of becoming pregnant, or breast-feeding.

Ask your doctor or pharmacist before taking or using any medicines.

Driving and using machines

AMETOP Gel is unlikely to affect driving or the use of machines.

AMETOP Gel contains sodium methyl

parahydroxybenzoate (E219) and sodium propyl parahydroxybenzoate (E217) which may cause allergic reactions (possibly delayed).

3. How to use AMETOP Gel

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Adults including the elderly:

A maximum of 5 tubes (approximately 5g) can be applied at separate sites at the same time. Application of AMETOP Gel can be repeated after a minimum of 5 hours if necessary. The maximum dose in a 24-hour period should not exceed 7 tubes. Use in children:

Infants over 1 month of age and children under 5 years of age:

  • A maximum of 1 tube (approximately 1g) can be applied at separate sites at a single time. Application of AMETOP Gel can be repeated after a minimum of 5 hours if necessary. The maximum dose in a 24-hour period should not exceed 2 tubes.
  • Do not use if the patient is less than 1 month old or if the patient is a premature baby up until one month after the expected delivery date (44 weeks gestation).

Children over 5 years of age:

A maximum of 5 tubes (approximately 5g) can be applied at separate sites at the same time. Application of AMETOP Gel can be repeated after a minimum of 5 hours if necessary. The maximum dose in a 24-hour period should not exceed 7 tubes. PATIENT INFORMATION LEAFLET

0918202 Your doctor, nurse or pharmacist will tell you where on the skin you need to apply the medicine. One tube of AMETOP Gel can cover an area of up to 30 sq cm (6cm x 5cm or 2½in. x 2in.).

This medicine may be administered by a doctor, nurse or pharmacist. If not, you should carry out the following steps:

  • To open the tube, invert

    the cap and pierce the

    seal.

  • Apply the contents of the

    tube on the area of the

    skin to be numbed. Do

    not rub the gel into the

    skin.

  • The mound of gel should

    then be covered with a

    plastic film dressing which

    may be supplied by your

    doctor or pharmacist.

  • Each tube is intended for

    use on a single occasion

    only

How to apply the plasticfilm dressing

Apply the plastic film

dressing as per the

manufacturer’s instructions.

  • Place the dressing over

    the mound of gel and

    down around the edges

    of the gel.

  • If no plastic dressing is

    supplied to you, the

    mound of gel can be

    covered by clear plastic

    kitchen wrap.

  • The gel must be covered

    for it to work.

  • It will not work if you rub it

    in like an ointment.

After 30-45 minutes, or as recommended by your doctor or pharmacist:

  • The dressing should be removed and the gel wiped off the skin with a clean tissue
  • Dispose of these carefully out of the reach of children
  • AMETOP Gel should not be left on for more than 45 minutes
  • The site will remain numb for about 4-6 hours. Take care to minimise contact with AMETOP Gel (except for the area of skin to be numbed) during application and removal. Allergic reactions to this product can occur, especially following repeated contact. It may be advisable to use a finger cot or rubber glove during application and removal of AMETOP Gel. Always wash hands thoroughly after use.

If the product comes into contact with the eyes, ears, mouth, tongue or nose you should immediately rinse the affected area and contact your doctor or pharmacist for further advice. Only apply to intact, healthy skin.

If you use more AMETOP Gel than you should or if you swallow AMETOP Gel

You may experience intoxication, tingling, numbness in your tongue, ringing in your ears (tinnitus), uncontrolled rapid jerky movement of the eyes, feeling sick or actually being sick, twitching and fitting. You should contact your doctor immediately.

4. Possible side effects

Like all medicines AMETOP Gel can cause side effects, although not everyone gets them. The following side effects may happen with this medicine:

Common: may affect up to 1 in 10 people

  • redness of the skin at the numbed site (more severe redness has rarely been reported). Uncommon: may affect up to 1 in 100 people
  • itching and swelling of the skin at the numbed site (more severe itching and swelling have rarely been reported).

Very rare: may affect up to 1 in 10,000 people

  • blistering of the skin at the numbed site. If blistering occurs remove the AMETOP Gel immediately using a clean tissue and contact your doctor or pharmacist.

The risk of these side effects happening may increase with repeated use.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store AMETOP Gel

  • Keep out of the sight and reach of children.
  • Use once, then discard.
  • Store in a refrigerator at 2-8°C. Do not freeze. Protect from heat.
  • If not stored in a refrigerator AMETOP Gel must be used within 1 month.
  • The expiry date is printed on the base of the tube and on the carton (MM/YYYY). The medicine can be used until the end of the month stated. Do not use your medicine after this date.
  • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other Information

What AMETOP Gel contains

  • The active substance tetracaine 4% w/w.
  • AMETOP Gel: the other ingredients are purified water, sodium chloride, potassium dihydrogen phosphate, xanthan gum (E415), sodium hydroxide (E524) and sodium methyl parahydroxybenzoate (E219) and sodium propyl parahydroxybenzoate (E217).

What AMETOP Gel looks like and the contents of the pack

AMETOP Gel is a white semi-transparent gel. Each gram of gel contains 40mg of tetracaine. Each tube contains 1.5g of AMETOP Gel from which 1g (40mg tetracaine) can be squeezed.

Marketing Authorisation Holder

Universal Medicines Limited, 83-85 Baker Street, London, W1U 6AG, UK.

Manufacturer

Perstorp Specialty Chemicals AB,

Perstorp Pharma, SE-284 80 Perstorp, Sweden. This leaflet was last revised: June 2026

  1. 1.

    Pierce nozzle using spiked cap. Empty tube to form a

    mound of gel at required site.

  2. 2.

    Smooth down edges of dressing. Record the time of completed

    application.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 60688/0003

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ametop gel 4% w/w

Prescription needed? No, but it is sold only in pharmacies (P)
Active substance Tetracaine
Strength 4% w/w (40 mg/gram)
Pharmaceutical form Cutaneous gel
How is it taken Cutaneous
Excipients Sodium Hydroxide (E524), Sodium methyl-p-hydroxybenzoate (E219), Sodium propyl-p-hydroxybenzoate (E217), Monobasic potassium phosphate, Xanthan gum (E415), Sodium chloride, Purified water
Pack sizes 1.5 gram, 18 gram
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life The shelf- life should not exceed 24 months from the date of manufacture. Within the recommended shelf-life of 2 years at 2-8°C, the product, following dispensing may be stored for up to 1 month at 25°C at point of use.
Storage Store at 2 - 8°C. Do not freeze. Protect from heat.
Drug group (ATC) Anaesthetics, Local
  1. N Nervous system drugs
    1. N01 Anesthetics
      1. N01B Local anesthetics
        1. N01BA Esters of aminobenzoic acid for local anesthesia
          1. N01BA03 tetracaine
Marketing authorisation PL 60688/0003 (first authorised 10 July 1995)
Marketing authorisation holder Universal Medicines Limited
Codes GTIN 0000096190449 · BNF 15020100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.